Company Filing History:
Years Active: 2006
Title: Innovator Risto Penttinen - Pioneering Advances in Biologically Active Agents
Introduction
Risto Penttinen, located in Turku, Finland, is an accomplished inventor recognized for his contributions to the field of biologically active agent delivery systems. With two patents to his name, his work primarily focuses on enhancing the effectiveness of therapeutic agents through innovative compositions and materials.
Latest Patents
Risto Penttinen's latest patents illustrate his commitment to innovative solutions in medical technology. His first patent, titled "Compositions for controlled release of a biologically active agent, and the preparation thereof," presents a unique composition for the controlled release of heparin or related biologically active acidic polysaccharides. This composition utilizes a sol-gel derived silica xerogel, which is synthesized from tetraalkoxysilane, specifically tetrethoxysilane (TEOS). The innovation lies in the partial replacement of the tetraalkoxysilane with an organomodified alkoxysilane, preferably an alkyl-substituted alkoxysilane. This patent also encompasses methods for preparing the composition, thereby offering significant advancements in drug delivery systems.
His second patent, "Multilayered material bearing a biologically active agent and the preparation thereof," further underscores his inventive prowess. This material is designed for medical use in humans and animals and features a multilayered construction. The core material, which can resemble a finished medical device, is coated with two or more layers. Importantly, at least one of these layers incorporates a biologically active agent. Risto’s innovation also includes utilizing biopolymers, sol-gel-derived silica gels, or biologically active molecules as coating materials, showcasing his versatility in materials science.
Career Highlights
Risto Penttinen works for Delsitech Oy, a company known for its focus on developing advanced materials and technologies for medical applications. His expertise has not only led to patent grants but also positioned him as a key figure in driving innovation within the company.
Collaborations
Throughout his career, Risto has collaborated with talented professionals such as Manja Ahola and Antti Yli-Urpo. These collaborations have contributed to multidisciplinary approaches in developing cutting-edge technologies that meet the needs of the medical industry.
Conclusion
Risto Penttinen exemplifies the spirit of innovation through his patents that significantly improve the delivery of biologically active agents. His work at Delsitech Oy, supported by collaborations with renowned colleagues, firmly places him at the forefront of medical technology advancements. As he continues to push the boundaries of innovation, the implications of his work are sure to inspire future developments in the field.